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1. Introduction
While infectious diseases constituted the most serious
global health issue until the middle of the 20th century
[1]; nowadays, the cardiovascular and metabolic diseases
are the largest contributors to global morbimortality [2].
Interestingly, if in the past centuries, bacteria were considered
a potential threat to health, currently, it is well known that in
normal conditions in some body compartments, such as the
gut, there is a pool of microbe that is majorly composed of
nonpathogenic microorganisms (“nice guys”) that are
relevant to oppose the progression of several chronic diseases.
Moreover, recent studies have revealed that diseases related
with dysbiosis of the gutmicrobiota are linkedwith an exacer-
bated oxidative stress [3]. Recent data have revealed that
the healthy bacteria of gut microbiota may promote a
physiological cross-talk with other systems such as the
brain, cardiovascular organs, and metabolic-related tissues,
helping to avoid and fight hypertension and metabolic
syndrome progression [3]. In parallel, other studies demon-
strated that the disturbance of gut microbiota (triggered
and caused by urban diets and sedentary lifestyle) may result
in excessive bioavailability of reactive oxygen species (ROS)
and contribute to the increase of oxidative stress [4].
Therefore, the three terms used in the title of this special
issue: gut microbiota, diet, and chronic diseases, that have
sounded so discrepant until the last century begin to have a
stronger meaning in the present century, as illustrated in
Figure 1. However, a further and wide investigation is still
necessary to reach a better understanding about the interac-
tions either through the influence of microbiota and diet or
through pharmacological strategies.
The special issue comprises one review article and
innovative research papers that provide new insights about
the potential benefits and molecular mechanisms of nutra-
ceuticals and their antioxidant actions, as summarized below.
The review provides a state-of-the-art role showing
strong evidence of the effects of the probiotic kefir in the
prevention and treatment of gut dysbiosis in cardiometabolic
disturbances. The authors discuss about the improvement of
autonomic control of cardiovascular function and provide
beneficial effects of this kind of nutraceutical in patients
suffering heart failure. They also provide details and new
insights about the molecular mechanisms by which kefir
decreases oxidative stress in such conditions. The review con-
tains 5 schematic figures that can be used by the readers as an
updated source of knowledge about the mechanisms related
with the treatment of chronic diseases by using probiotics [5].
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The translational original paper presented by L. A.
Chisté et al. [6] is related with novel insights about the
prooxidative and genotoxic effect of sugar-sweetened soft
drinks (but not zero soft drinks) and other questions that
remain to be addressed concerning the consumption of
commercial beverages. This innovative investigation con-
ducted in the laboratory of Pereira and Campagnaro, using
a mouse model of dyslipidemia, may effectively provide a
basis for further experimental and clinical studies to explore
the association between the consumption of soft drinks and
metabolic diseases.
Interestingly, Chinese researchers [7] report in this issue
data showing that neonatal supplementation of oxygen ther-
apy may compromise the nephrogenesis process. The
authors highlight the importance of MAPK/ERK signaling,
HIF-1α, or catalase to protect against hyperoxia-induced
oxidative damage in neonatal proximal tubules. Their study
may open some news avenues that can provide the under-
standing of etiology cases of nephrogenesis impairment.
It is known that overproduction/accumulation of
butyrate (a short-chain fatty acid of ruminal fermentation)
in the bowel may promote toxic effects in the intestinal
mucosa. A second group of Chinese researchers [8] present
an interesting data showing that vitamin B3 (niacin) can
inhibit butyrate-induced apoptosis of rumen epithelial cells.
This protective effect reported by the authors is probably
associated with reduced oxidative stress, inhibition of
caspase-3 and p53 activation, and DNA-damage repair. The
importance of that study is that it expands strategies to
mitigate the damage produced by the excessive exposition
of short-chain fatty acids. In the same field of research, a
second group from China [9] describes the protective effects
exhibited by methane-rich saline on acetic acid-induced
ulcerative colitis and describes that this approach culminates
with antioxidative and anti-inflammatory effects. The
authors emphasize that this approach could be anti-
inflammatory and antiapoptotic therapeutic alternatives
through the inhibition of TLR4/NF-κB/MAPK signaling
pathway and promoting IL-10/JAK1/STAT3.
Considering that Salmonella infection is frequently
observed worldwide and often is resistant to prolonged anti-
biotic treatment, the search for innovative antibiotics against
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Figure 1: Follow-up of a decade of published papers related with the association between the three keywords: gut microbiota, diet, and
chronic diseases, based on PubMed indexation. Data source: https://www.ncbi.nlm.nih.gov/pubmed/.
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Figure 2: (a) Schematic diagram showing alternative therapies proposed in this special issue that exhibit antioxidative properties and become
potential promissing approaches. (b) illustrates the deleterious actions of hyperoxia exposition that contributes to the worsening of the renal
function and that is not yet tested with those therapies.
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these gram-negative bacteria deserves urgent attention. In
this regard, the paper published by O. A. S. Mayorga et al.
[10] demonstrates that exposition to species rich in flavo-
noids, the Kalanchoe brasiliensis, has beneficial antibacterial
effects against Salmonella strains, by an interesting mecha-
nism that comprises cell membrane integrity and/or perme-
ability alterations. This discovery published in this special
issue by Brazilian researchers deserves special merit because
it can provide good candidates to reach the goal of new anti-
biotics for therapeutic applications against Salmonella spp.
In conclusion, the readers will find interesting papers that
were accepted and published in this special issue because
even if the data are from independent researchers and labora-
tories, they demonstrate that different alternative therapies/-
supplements/diets have a molecular mechanism of action
converging to anti-ROS action with distinct consequences,
as illustrated in a schematic diagram (Figure 2).
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